Lung Screening Articles & Analysis
13 news found
The lung cancer screening demonstration project led by Dr Simon Martel, pulmonologist at the Quebec Heart and Lung Institute (Institut Universitaire de Cardiologie et Pneumologie de Québec-Université Laval – IUCPQ-UL) is intended to combine BioMark’s metabolomics liquid biopsy test with radiomics and genetics biomarkers ...
Abstract title: “Metabolomic Profiling for the Early Detection of Lung Cancer”. The results demonstrated the high accuracy of BioMark’s quantitative metabolomic platform to identify early-stage lung cancer in retrospective plasma samples from individual with smoking history compared to participants suffering from other lung ...
” With FRI images, the patient would likely better comprehend the condition of their lungs and how their respiratory functioning improves over the course of the prescribed treatment. ...
ByFluidda
The Company will be presenting clinical data using its quantitative metabolomic platform to identify early-stage lung cancer in retrospective plasma samples from individual with smoking history, or suffering from other lung diseases including asthma, COPD, bronchiectasis and COVID. ...
This is very encouraging to know that this group of strategic investors have deep conviction on BioMark’s cancer diagnostic platform and its ability to commercialize its dynamic early lung cancer test within the next 12-18 months,” says Rashid Bux CEO and President of BioMark. In conjunction with the private round of financing, the Company was also successful in ...
“Colorectal cancer screening is the start of this journey. We will soon expand into multi-cancer screening, including lung, pancreas and others, where we believe cancer screening can save ...
Preventive Services Task Force recommends yearly lung cancer screening using a low-dose computed tomography (CT) scan for people ages 50 to 80 years old who are at high risk for lung cancer because of their smoking history, but who don’t have signs or symptoms.2 Despite these recommendations, only 14% of people eligible for a low-dose CT ...
Using robotic technology, the MONARCH® Platform provides physicians with precision and continuous visualization to reach and diagnose nodules deep in the lung. To highlight the importance of lung cancer screening, Auris is sharing key insights from the report, and which groups may be at a higher risk for the disease. ...
Innovative approach In this project we will apply an entirely new approach called « environmental interference » to fight fungal infection. It exploits the ecology of the lung microbiota by using airway bacteria with the aim to alter the lung microenvironment to fight the lung infection by stopping the proliferation of fungi. ...
Innovative approach In this project we will apply an entirely new approach called « environmental interference » to fight fungal infection. It exploits the ecology of the lung microbiota by using airway bacteria with the aim to alter the lung microenvironment to fight the lung infection by stopping the proliferation of fungi. ...
The next-generation sequencing (NGS) solutions will be used in two prospective, observational projects to support the development of future therapeutics and diagnostics for non-small cell lung cancer (NSCLC). The Lung Cancer Genomic Screening Project for Individualized Medicine in Asia aims to overcome challenges in establishing precision ...
Lung cancer screening helps detect lung cancer earlier, before symptoms occur, when it is more treatable and can be cured. Who should be screened? The U.S. Preventive Services Task Force recommends yearly lung cancer screening for people who: Have a history of heavy smoking, and Smoke now or ...
Anyone interested in having a free screening of his/her lung function can come and visit us at Piazza della Mostra from 9:00 until ...